AstraZeneca PLC
AZNCF
$135.88
$0.520.38%
OTC PK
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 5.40B | 5.53B | 4.93B | 7.08B | 8.02B |
Total Receivables | 14.82B | 13.09B | 13.55B | 12.62B | 12.23B |
Inventory | 5.88B | 5.29B | 5.66B | 5.67B | 5.34B |
Prepaid Expenses | -- | 1.74B | -- | -- | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 45.00M | 183.00M | 16.00M | 28.00M | 11.00M |
Total Current Assets | 26.14B | 25.83B | 24.16B | 25.39B | 25.59B |
|
|||||
Total Current Assets | 26.14B | 25.83B | 24.16B | 25.39B | 25.59B |
Net Property, Plant & Equipment | 12.30B | 11.65B | 11.51B | 10.83B | 10.62B |
Long-term Investments | 21.13B | 21.03B | 21.14B | 21.06B | 19.98B |
Goodwill | 21.13B | 21.03B | 21.14B | 21.06B | 19.98B |
Total Other Intangibles | 37.55B | 37.18B | 39.39B | 39.43B | 38.83B |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 7.23B | 6.46B | 6.58B | 5.76B | 5.58B |
Total Assets | 106.25B | 104.04B | 104.92B | 104.34B | 102.29B |
|
|||||
Total Accounts Payable | 22.54B | 3.64B | 21.68B | 20.46B | 19.70B |
Total Accrued Expenses | -- | 16.09B | -- | -- | -- |
Short-term Debt | 1.39B | 330.00M | 1.24B | 3.05B | 1.46B |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 2.39B | 2.40B | 346.00M | 2.36B | 4.97B |
Total Finance Division Other Current Liabilities | 2.81B | 5.41B | 2.66B | 2.69B | 2.78B |
Total Other Current Liabilities | 2.81B | 5.41B | 2.66B | 2.69B | 2.78B |
Total Current Liabilities | 29.13B | 27.87B | 25.93B | 28.57B | 28.90B |
|
|||||
Total Current Liabilities | 29.13B | 27.87B | 25.93B | 28.57B | 28.90B |
Long-Term Debt | 26.74B | 26.62B | 28.92B | 27.29B | 27.31B |
Short-term Debt | 1.39B | 330.00M | 1.24B | 3.05B | 1.46B |
Capital Leases | 1.20B | 1.11B | 1.11B | 949.00M | 961.00M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 8.06B | 7.56B | 8.17B | 7.94B | 7.62B |
Total Liabilities | 65.12B | 63.16B | 64.12B | 64.74B | 64.79B |
|
|||||
Common Stock & APIC | 35.62B | 35.61B | 35.59B | 35.59B | 35.58B |
Retained Earnings | 3.36B | 7.23B | 3.14B | 1.85B | -212.00M |
Treasury Stock & Other | 2.05B | -2.06B | 1.99B | 2.08B | 2.08B |
Total Common Equity | 41.04B | 40.79B | 40.72B | 39.51B | 37.45B |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 41.04B | 40.79B | 40.72B | 39.51B | 37.45B |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | 92.00M | 85.00M | 86.00M | 86.00M | 56.00M |
Total Equity | 41.13B | 40.87B | 40.81B | 39.60B | 37.50B |
|